Change in renal function after sodium phosphate preparation for screening colonoscopy

World Journal of Gastroenterology

Volumn 16, Issue 16, 2010, Pages 2010-2016

  Seol, Dong Choon ^a   Hong, Sung Noh ^b   Kim, Jeong Hwan ^a   Sung, In Kyung ^b   Park, Hyung Seok ^b   Lee, Jung Hyun ^b   Shim, Chan Sup ^b  

^a Konkuk University School of Medicine   (South Korea)

^b Konkuk University Hospital   (South Korea)

Author keywords

Colonoscopy; Creatinine; Glomerular filtration rate; Polyethylene glycol; Purgatives; Sodium phosphate

Indexed keywords

COLYTE 4L; CREATINE; FLEET; MACROGOL; SODIUM DIHYDROGEN PHOSPHATE; UNCLASSIFIED DRUG;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; COLONOSCOPY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG SAFETY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INTESTINE PREPARATION; KIDNEY FUNCTION; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MULTIPLE LINEAR REGRESSION ANALYSIS;

EID: 77951941098     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i16.2010     Document Type: Article

References (28)

1. Bond JH. Should the quality of preparation impact postcolonoscopy follow-up recommendations? Am J Gastroenterol 2007; 102: 2686-2687
2. Tan JJ, Tjandra JJ. Which is the optimal bowel preparation for colonoscopy - a meta-analysis. Colorectal Dis 2006; 8: 247-258
3. Hsu CW, Imperiale TF. Meta-analysis and cost comparison of polyethylene glycol lavage versus sodium phosphate for colonoscopy preparation. Gastrointest Endosc 1998; 48: 276-282
4. Carl DE, Sica DA. Acute phosphate nephropathy following colonoscopy preparation. Am J Med Sci 2007; 334: 151-154
5. Fine A, Patterson J. Severe hyperphosphatemia following phosphate administration for bowel preparation in patients with renal failure: two cases and a review of the literature. Am J Kidney Dis 1997; 29: 103-105
6. Markowitz GS, Nasr SH, Klein P, Anderson H, Stack JI, Alterman L, Price B, Radhakrishnan J, D'Agati VD. Renal failure due to acute nephrocalcinosis following oral sodium phosphate bowel cleansing. Hum Pathol 2004; 35: 675-684
7. Orias M, Mahnensmith RL, Perazella MA. Extreme hyperphosphatemia and acute renal failure after a phosphorusontaining bowel regimen. Am J Nephrol 1999; 19: 60-63
8. Ullah N, Yeh R, Ehrinpreis M. Fatal hyperphosphatemia from a phosphosoda bowel preparation. J Clin Gastroenterol 2002; 34: 457-458
9. Abaskharoun R, Depew W, Vanner S. Changes in renal function following administration of oral sodium phosphate or polyethylene glycol for colon cleansing before colonoscopy. Can J Gastroenterol 2007; 21: 227-231
10. Brunelli SM, Lewis JD, Gupta M, Latif SM, Weiner MG, Feldman HI. Risk of kidney injury following oral phosphosoda bowel preparations. J Am Soc Nephrol 2007; 18: 3199-3205
11. Hurst FP, Bohen EM, Osgard EM, Oliver DK, Das NP, Gao SW, Abbott KC. Association of oral sodium phosphate purgative use with acute kidney injury. J Am Soc Nephrol 2007; 18: 3192-3198
12. Khurana A, McLean L, Atkinson S, Foulks CJ. The effect of oral sodium phosphate drug products on renal function in adults undergoing bowel endoscopy. Arch Intern Med 2008; 168: 593-597
13. Russmann S, Lamerato L, Marfatia A, Motsko SP, Pezzullo JC, Olds G, Jones JK. Risk of impaired renal function after colonoscopy: a cohort study in patients receiving either oral sodium phosphate or polyethylene glycol. Am J Gastroenterol 2007; 102: 2655-2663
14. Singal AK, Rosman AS, Post JB, Bauman WA, Spungen AM, Korsten MA. The renal safety of bowel preparations for colonoscopy: a comparative study of oral sodium phosphate solution and polyethylene glycol. Aliment Pharmacol Ther 2008; 27: 41-47
15. Ladabaum U, Song K. Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand. Gastroenterology 2005; 129: 1151-1162
16. Belsey J, Epstein O, Heresbach D. Systematic review: oral bowel preparation for colonoscopy. Aliment Pharmacol Ther 2007; 25: 373-384
17. Shawki S, Wexner SD. How safe is bowel preparation with oral sodium phosphate solution? Nat Clin Pract Gastroenterol Hepatol 2008; 5: 482-483
18. Markowitz GS, Stokes MB, Radhakrishnan J, D'Agati VD. Acute phosphate nephropathy following oral sodium phos-phate bowel purgative: an underrecognized cause of chronic renal failure. J Am Soc Nephrol 2005; 16: 3389-3396
19. Brunelli SM. Association between oral sodium phosphate bowel preparations and kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009; 53: 448-456
20. Brady CE 3rd, DiPalma JA, Morawski SG, Santa Ana CA, Fordtran JS. Urinary excretion of polyethylene glycol 3350 and sulfate after gut lavage with a polyethylene glycol electrolyte lavage solution. Gastroenterology 1986; 90: 1914-1918
21. Tusing TW, Elsea JR, Sauveur AB. The chronic dermal toxicity of a series of polyethylene glycols. J Am Pharm Assoc Am Pharm Assoc (Baltim) 1954; 43: 489-490
22. Russmann S, Lamerato L, Motsko SP, Pezzullo JC, Faber MD, Jones JK. Risk of further decline in renal function after the use of oral sodium phosphate or polyethylene glycol in patients with a preexisting glomerular filtration rate below 60 ml/min. Am J Gastroenterol 2008; 103: 2707-2716
23. Lieberman DA, Ghormley J, Flora K. Effect of oral sodium phosphate colon preparation on serum electrolytes in patients with normal serum creatinine. Gastrointest Endosc 1996; 43: 467-469
24. Casais MN, Rosa-Diez G, Pérez S, Mansilla EN, Bravo S, Bonofiglio FC. Hyperphosphatemia after sodium phosphate laxatives in low risk patients: prospective study. World J Gastroenterol 2009; 15: 5960-5965
25. Ainley EJ, Winwood PJ, Begley JP. Measurement of serum electrolytes and phosphate after sodium phosphate colonoscopy bowel preparation: an evaluation. Dig Dis Sci 2005; 50: 1319-1323
26. Zager RA. Hyperphosphatemia: a factor that provokes severe experimental acute renal failure. J Lab Clin Med 1982; 100: 230-239
27. Ibels LS, Alfrey AC, Haut L, Huffer WE. Preservation of function in experimental renal disease by dietary restriction of phosphate. N Engl J Med 1978; 298: 122-126
28. Nagano N, Miyata S, Obana S, Kobayashi N, Fukushima N, Burke SK, Wada M. Sevelamer hydrochloride, a phosphate binder, protects against deterioration of renal function in rats with progressive chronic renal insufficiency. Nephrol Dial Transplant 2003; 18: 2014-2023